Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype

Linlin Wang, John M. Peters, Franklin Fuda, Long Li, Nitin J. Karandikar, Prasad Koduru, Huan You Wang, Weina Chen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background Acute megakaryoblastic leukemia (AMKL) is a rare form of acute myeloid leukemia that encompasses three distinct subgroups: children with Down syndrome (DS-AMKL), children without DS (non-DS-AMKL), and adults (adult-AMKL). We hypothesize that the biological differences in the subtypes of AMKL may be reflected in distinct immunophenotypic (IP) features. Our aims were to employ mutiparameter flow cytometry to establish a comprehensive IP spectrum of AMKL in multiple demographic groups and to determine whether the subtypes of AMKL demonstrate distinct immunophenotypes. Methods Thirty-seven AMKL cases were retrieved and subdivided into these three groups. Multiparameter flow cytometry was used to determine and compare the immunophenotypes. Available clinical, cytogenetic, and morphologic data were reviewed to confirm diagnoses. Results While there is commonality in the expression pattern for a wide range of myelomonocytic markers in these three subtypes of AMKL, blasts in DS-AMKL were more likely to express CD7 and CD11b than those in non-DS-AMKL and adult-AMKL. Furthermore, blasts in DS-AMKL were more likely to express CD13, CD33, and CD36 than non-DS pediatric AMKL, and showed greater CD56 expression compared with adult AMKL. Conclusions These results indicate that DS-AMKL is related to but immunophenotypically distinct from non-DS-AMKL and adult-AMKL. This distinct immunophenotypic pattern, co-expression of CD7 and CD11b, has practical implications for characterization of AMKL.

Original languageEnglish (US)
Pages (from-to)244-252
Number of pages9
JournalCytometry Part B - Clinical Cytometry
Volume88
Issue number4
DOIs
StatePublished - Jul 1 2015

Fingerprint

Leukemia, Megakaryoblastic, Acute
Down Syndrome
Flow Cytometry

Keywords

  • acute megakaryoblastic leukemia
  • Down syndrome
  • flow cytometry
  • immunophenotype

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Pathology and Forensic Medicine

Cite this

Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype. / Wang, Linlin; Peters, John M.; Fuda, Franklin; Li, Long; Karandikar, Nitin J.; Koduru, Prasad; Wang, Huan You; Chen, Weina.

In: Cytometry Part B - Clinical Cytometry, Vol. 88, No. 4, 01.07.2015, p. 244-252.

Research output: Contribution to journalArticle

Wang, Linlin ; Peters, John M. ; Fuda, Franklin ; Li, Long ; Karandikar, Nitin J. ; Koduru, Prasad ; Wang, Huan You ; Chen, Weina. / Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype. In: Cytometry Part B - Clinical Cytometry. 2015 ; Vol. 88, No. 4. pp. 244-252.
@article{8799ecaae60844e18fed5067f2f3fef1,
title = "Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype",
abstract = "Background Acute megakaryoblastic leukemia (AMKL) is a rare form of acute myeloid leukemia that encompasses three distinct subgroups: children with Down syndrome (DS-AMKL), children without DS (non-DS-AMKL), and adults (adult-AMKL). We hypothesize that the biological differences in the subtypes of AMKL may be reflected in distinct immunophenotypic (IP) features. Our aims were to employ mutiparameter flow cytometry to establish a comprehensive IP spectrum of AMKL in multiple demographic groups and to determine whether the subtypes of AMKL demonstrate distinct immunophenotypes. Methods Thirty-seven AMKL cases were retrieved and subdivided into these three groups. Multiparameter flow cytometry was used to determine and compare the immunophenotypes. Available clinical, cytogenetic, and morphologic data were reviewed to confirm diagnoses. Results While there is commonality in the expression pattern for a wide range of myelomonocytic markers in these three subtypes of AMKL, blasts in DS-AMKL were more likely to express CD7 and CD11b than those in non-DS-AMKL and adult-AMKL. Furthermore, blasts in DS-AMKL were more likely to express CD13, CD33, and CD36 than non-DS pediatric AMKL, and showed greater CD56 expression compared with adult AMKL. Conclusions These results indicate that DS-AMKL is related to but immunophenotypically distinct from non-DS-AMKL and adult-AMKL. This distinct immunophenotypic pattern, co-expression of CD7 and CD11b, has practical implications for characterization of AMKL.",
keywords = "acute megakaryoblastic leukemia, Down syndrome, flow cytometry, immunophenotype",
author = "Linlin Wang and Peters, {John M.} and Franklin Fuda and Long Li and Karandikar, {Nitin J.} and Prasad Koduru and Wang, {Huan You} and Weina Chen",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/cyto.b.21198",
language = "English (US)",
volume = "88",
pages = "244--252",
journal = "Cytometry Part B - Clinical Cytometry",
issn = "1552-4949",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype

AU - Wang, Linlin

AU - Peters, John M.

AU - Fuda, Franklin

AU - Li, Long

AU - Karandikar, Nitin J.

AU - Koduru, Prasad

AU - Wang, Huan You

AU - Chen, Weina

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background Acute megakaryoblastic leukemia (AMKL) is a rare form of acute myeloid leukemia that encompasses three distinct subgroups: children with Down syndrome (DS-AMKL), children without DS (non-DS-AMKL), and adults (adult-AMKL). We hypothesize that the biological differences in the subtypes of AMKL may be reflected in distinct immunophenotypic (IP) features. Our aims were to employ mutiparameter flow cytometry to establish a comprehensive IP spectrum of AMKL in multiple demographic groups and to determine whether the subtypes of AMKL demonstrate distinct immunophenotypes. Methods Thirty-seven AMKL cases were retrieved and subdivided into these three groups. Multiparameter flow cytometry was used to determine and compare the immunophenotypes. Available clinical, cytogenetic, and morphologic data were reviewed to confirm diagnoses. Results While there is commonality in the expression pattern for a wide range of myelomonocytic markers in these three subtypes of AMKL, blasts in DS-AMKL were more likely to express CD7 and CD11b than those in non-DS-AMKL and adult-AMKL. Furthermore, blasts in DS-AMKL were more likely to express CD13, CD33, and CD36 than non-DS pediatric AMKL, and showed greater CD56 expression compared with adult AMKL. Conclusions These results indicate that DS-AMKL is related to but immunophenotypically distinct from non-DS-AMKL and adult-AMKL. This distinct immunophenotypic pattern, co-expression of CD7 and CD11b, has practical implications for characterization of AMKL.

AB - Background Acute megakaryoblastic leukemia (AMKL) is a rare form of acute myeloid leukemia that encompasses three distinct subgroups: children with Down syndrome (DS-AMKL), children without DS (non-DS-AMKL), and adults (adult-AMKL). We hypothesize that the biological differences in the subtypes of AMKL may be reflected in distinct immunophenotypic (IP) features. Our aims were to employ mutiparameter flow cytometry to establish a comprehensive IP spectrum of AMKL in multiple demographic groups and to determine whether the subtypes of AMKL demonstrate distinct immunophenotypes. Methods Thirty-seven AMKL cases were retrieved and subdivided into these three groups. Multiparameter flow cytometry was used to determine and compare the immunophenotypes. Available clinical, cytogenetic, and morphologic data were reviewed to confirm diagnoses. Results While there is commonality in the expression pattern for a wide range of myelomonocytic markers in these three subtypes of AMKL, blasts in DS-AMKL were more likely to express CD7 and CD11b than those in non-DS-AMKL and adult-AMKL. Furthermore, blasts in DS-AMKL were more likely to express CD13, CD33, and CD36 than non-DS pediatric AMKL, and showed greater CD56 expression compared with adult AMKL. Conclusions These results indicate that DS-AMKL is related to but immunophenotypically distinct from non-DS-AMKL and adult-AMKL. This distinct immunophenotypic pattern, co-expression of CD7 and CD11b, has practical implications for characterization of AMKL.

KW - acute megakaryoblastic leukemia

KW - Down syndrome

KW - flow cytometry

KW - immunophenotype

UR - http://www.scopus.com/inward/record.url?scp=84932113811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932113811&partnerID=8YFLogxK

U2 - 10.1002/cyto.b.21198

DO - 10.1002/cyto.b.21198

M3 - Article

C2 - 25361478

AN - SCOPUS:84932113811

VL - 88

SP - 244

EP - 252

JO - Cytometry Part B - Clinical Cytometry

JF - Cytometry Part B - Clinical Cytometry

SN - 1552-4949

IS - 4

ER -